Both in Diagnostics
QuidelOrtho vs Immucell
Over the past year QDEL returned −47.1% and ICCC returned +72.8%; their daily moves had a correlation of 0.06.
QDEL −47.1% ICCC +72.8%Growth of $1, one year, split-adjusted
| Metric | QDEL | ICCC |
|---|---|---|
| Price | $14.35 | $10.37 |
| Market cap | $984.1M | $94.2M |
| Today | +1.85% | +1.17% |
| 1 month | +14.2% | +4.0% |
| 6 months | +30.9% | +19.7% |
| Year to date | −49.8% | +68.6% |
| 1 year | −48.2% | +67.0% |
| Revenue growth (YoY) | +2.8% | +11.5% |
| Gross margin | 43.3% | 33.9% |
| Net margin | −14.7% | 25.5% |
| P/E (TTM) | — | 119.6× |
| Price / sales | 0.4× | 3.1× |
| Net cash | -$2.77B | $557.3K |
| Dividend yield | — | — |
| Volatility (60d) | 65.8% | 38.4% |
| Short % of float | 19.2% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).